Mammary carcinoma: toward a realistic mouse model of incurable cancers

As long as breast cancer (BC) stays under immunosurveillance, it can be controlled by treatments eliciting anticancer immune responses. However, once BC escapes immunosurveillance, it becomes therapeutically uncontrollable. A paper in the Journal for ImmunoTherapy of Cancer describes a new hormone r...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Lanzón, Maria, Maiuri, Maria Chiara, Lopez-Otin, Carlos, Kroemer, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402843/
https://www.ncbi.nlm.nih.gov/pubmed/37546695
http://dx.doi.org/10.1080/2162402X.2023.2240613
Descripción
Sumario:As long as breast cancer (BC) stays under immunosurveillance, it can be controlled by treatments eliciting anticancer immune responses. However, once BC escapes immunosurveillance, it becomes therapeutically uncontrollable. A paper in the Journal for ImmunoTherapy of Cancer describes a new hormone receptor-positive BC cell line generating incurable tumors in C57BL/6 mice.

Ejemplares similares